ORIC: ORIC Pharmaceuticals, Inc. Stock

by  •  • Comments Off on ORIC: ORIC Pharmaceuticals, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 333.12
Enterprise Value ($M) 273.71
Book Value ($M) 243.12
Book Value / Share 3.42
Price / Book 1.37
NCAV ($M) 231.23
NCAV / Share 3.26
Price / NCAV 1.44

Profitability (mra)
Return on Invested Capital (ROIC) -0.51
Return on Assets (ROA) -0.36
Return on Equity (ROE) -0.39

Liquidity (mrq)
Quick Ratio 10.56
Current Ratio 10.56

Balance Sheet (mrq) ($M)
Current Assets 262.25
Assets 274.14
Liabilities 31.02
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -142.90
Net Income -127.85

Cash Flow Statement (mra) ($M)
Cash From Operations -112.66
Cash from Investing 22.14
Cash from Financing 126.55

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-12 13G/A Fmr Llc 3.50 -43.64
11-14 13G/A Nextech Crossover I GP S.a r.l. 7.50 23.33
11-14 13G/A EcoR1 Capital, LLC 4.90 -45.53
11-14 13G/A Column Group Ii, Lp 5.20 -0.75
11-13 13G/A Alkeon Capital Management Llc 5.50 8.32
11-08 13G BlackRock, Inc. 7.20 0.00

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-02-18 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2024-11-12 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-08-12 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-05-06 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-04-17 34,327 449,542 7.64
2025-04-16 59,312 385,054 15.40
2025-04-15 85,809 543,854 15.78
2025-04-14 117,416 641,988 18.29

(click for more detail)

Similar Companies
OLMA – Olema Pharmaceuticals, Inc. OPK – OPKO Health, Inc.
OPTN – OptiNose, Inc. OVID – Ovid Therapeutics Inc.
PBYI – Puma Biotechnology, Inc.


Financial data and stock pages provided by
Fintel.io